• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿低度弥漫性胶质瘤的综合综述:病理学、分子遗传学与治疗

A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment.

作者信息

Ryall Scott, Tabori Uri, Hawkins Cynthia

机构信息

The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G1X8, Canada.

Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

出版信息

Brain Tumor Pathol. 2017 Apr;34(2):51-61. doi: 10.1007/s10014-017-0282-z. Epub 2017 Mar 25.

DOI:10.1007/s10014-017-0282-z
PMID:28342104
Abstract

Gliomas are the most common central nervous system neoplasms affecting children and can be both high- and low-grade. Paediatric low-grade glioma may be either World Health Organization grade I or grade II. Despite being classified as grade II diffuse astrocytoma, these neoplasms arising in children are distinct clinically and molecularly from their adult counterparts. They do not tend to progress to higher grade lesions and only rarely harbour an IDH mutation. Here, we review the clinical, histologic and molecular features of paediatric grade II diffuse glioma, highlighting their diagnostic criteria, prevalence across brain locations, their most common molecular features and how to test for them, and lastly the current status of therapeutic options available for their treatment.

摘要

胶质瘤是影响儿童的最常见中枢神经系统肿瘤,可分为高级别和低级别。儿童低级别胶质瘤可能是世界卫生组织一级或二级。尽管被归类为二级弥漫性星形细胞瘤,但这些发生在儿童中的肿瘤在临床和分子水平上与成人同类肿瘤不同。它们通常不会进展为更高级别的病变,只有极少数携带异柠檬酸脱氢酶(IDH)突变。在此,我们综述儿童二级弥漫性胶质瘤的临床、组织学和分子特征,重点介绍其诊断标准、在脑内各部位的患病率、最常见的分子特征及其检测方法,最后介绍目前可用于其治疗的治疗方案现状。

相似文献

1
A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment.小儿低度弥漫性胶质瘤的综合综述:病理学、分子遗传学与治疗
Brain Tumor Pathol. 2017 Apr;34(2):51-61. doi: 10.1007/s10014-017-0282-z. Epub 2017 Mar 25.
2
Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.描述儿科低级别胶质瘤的时间基因组异质性。
Acta Neuropathol Commun. 2020 Nov 5;8(1):182. doi: 10.1186/s40478-020-01054-w.
3
cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF mutation.cIMPACT-NOW更新4:以MYB、MYBL1或FGFR1改变或BRAF突变为特征的弥漫性胶质瘤
Acta Neuropathol. 2019 Apr;137(4):683-687. doi: 10.1007/s00401-019-01987-0. Epub 2019 Mar 8.
4
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.罕见低级别神经上皮肿瘤中的基因改变:BRAF、FGFR1和MYB突变高频发生且与形态学相符。
Acta Neuropathol. 2016 Jun;131(6):833-45. doi: 10.1007/s00401-016-1539-z. Epub 2016 Jan 25.
5
Pediatric low-grade glioma in the era of molecular diagnostics.儿童低级别胶质瘤的分子诊断时代。
Acta Neuropathol Commun. 2020 Mar 12;8(1):30. doi: 10.1186/s40478-020-00902-z.
6
New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.小儿神经胶质瘤的新策略:以小儿低级别神经胶质瘤为模型的分子进展。
Clin Cancer Res. 2013 Sep 1;19(17):4553-8. doi: 10.1158/1078-0432.CCR-13-0662. Epub 2013 Jul 23.
7
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.BRAF V600 突变的丘脑儿童低级别胶质瘤的临床病理研究。
Acta Neuropathol. 2015 Oct;130(4):575-85. doi: 10.1007/s00401-015-1467-3. Epub 2015 Aug 12.
8
[Clinicopathological and molecular characteristics of pediatric gliomas: analysis of 111 cases].小儿胶质瘤的临床病理及分子特征:111例分析
Zhonghua Bing Li Xue Za Zhi. 2024 Sep 8;53(9):922-928. doi: 10.3760/cma.j.cn112151-20240313-00163.
9
BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review.一名成年患者的BRAF V600E突变型弥漫性胶质瘤:病例报告及文献复习
Brain Tumor Pathol. 2016 Jan;33(1):40-9. doi: 10.1007/s10014-015-0234-4. Epub 2015 Oct 7.
10
Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.室管膜瘤和儿童弥漫性胶质瘤的分子遗传学:简短综述
Brain Tumor Pathol. 2014 Oct;31(4):229-33. doi: 10.1007/s10014-014-0200-6. Epub 2014 Sep 3.

引用本文的文献

1
FDA Approval Summary: Vorasidenib for IDH-mutant Grade 2 Astrocytoma or Oligodendroglioma following surgery.美国食品药品监督管理局(FDA)批准摘要:伏立西尼用于手术后的异柠檬酸脱氢酶(IDH)突变的2级星形细胞瘤或少突胶质细胞瘤。
Clin Cancer Res. 2025 Sep 5. doi: 10.1158/1078-0432.CCR-25-1333.
2
Pediatric-Type Diffuse Low-Grade Gliomas: A Subgroup Defined by Peculiar Molecular Features and Distinct Prognostic Outcomes.儿童型弥漫性低级别胶质瘤:一个由独特分子特征和不同预后结果所定义的亚组
Cureus. 2025 Jul 23;17(7):e88575. doi: 10.7759/cureus.88575. eCollection 2025 Jul.
3
Challenging CDKN2A assessment in BRAF-altered gliomas: lessons from a pleomorphic xanthoastrocytoma-enriched cohort.
BRAF 基因改变的胶质瘤中 CDKN2A 评估面临的挑战:来自富含多形性黄色星形细胞瘤队列的经验教训
Acta Neuropathol Commun. 2025 Aug 11;13(1):170. doi: 10.1186/s40478-025-02089-7.
4
Phenotypic and epigenetic heterogeneity in FGFR2-fused glial and glioneuronal tumours.FGFR2 融合型神经胶质和神经胶质神经元肿瘤的表型和表观遗传异质性。
Neuropathol Appl Neurobiol. 2024 Dec;50(6):e13014. doi: 10.1111/nan.13014.
5
Gene Expression Aberrations in Alcohol-Associated Hepatocellular Carcinoma.酒精相关性肝细胞癌中的基因表达异常。
Int J Mol Sci. 2024 Sep 30;25(19):10558. doi: 10.3390/ijms251910558.
6
Future perspective of targeted treatments in pediatric low-grade glioma (pLGG): the evolution of standard-of-care and challenges of a new era.儿科低级别胶质瘤(pLGG)靶向治疗的未来展望:标准治疗的演变和新时代的挑战。
Childs Nerv Syst. 2024 Oct;40(10):3291-3299. doi: 10.1007/s00381-024-06504-7. Epub 2024 Jul 31.
7
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients.儿童、青年及老年患者中异柠檬酸脱氢酶(IDH)突变型胶质瘤的比较分析。
Neuro Oncol. 2024 Dec 5;26(12):2364-2376. doi: 10.1093/neuonc/noae142.
8
Pediatric low-grade glioma models: advances and ongoing challenges.小儿低度胶质瘤模型:进展与持续挑战
Front Oncol. 2024 Jan 22;13:1346949. doi: 10.3389/fonc.2023.1346949. eCollection 2023.
9
Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma.儿科脑星形细胞瘤的遗传学和表观遗传学临床靶点的新见解。
Clin Transl Med. 2024 Feb;14(2):e1560. doi: 10.1002/ctm2.1560.
10
Identification and validation of a novel HOX-related classifier signature for predicting prognosis and immune microenvironment in pediatric gliomas.一种用于预测小儿胶质瘤预后和免疫微环境的新型HOX相关分类器特征的鉴定与验证
Front Cell Dev Biol. 2023 Jul 21;11:1203650. doi: 10.3389/fcell.2023.1203650. eCollection 2023.